Over the past couple of years, cannabidiol (“CBD”) has seen exponential growth in popularity. One of more than 100 cannabinoids produced by the hemp plant, CBD has potent and versatile medicinal properties. Preliminary research and anecdotal evidence have found the hemp extract to be effective at treating issues from anxiety and depression to insomnia and chronic pain. According to Gallup, 20% of Americans who use CBD do so to relieve anxiety.
However, not everyone who uses CBD to combat anxiety achieves the desired effects. Cannabidiol tends to react with each individual differently based on factors such as age, dosage and, body composition, although ultimately, the effects are more or less the same. However, there are a few common user mistakes to be aware of that could make CBD ineffective.
Using low-quality CBD products. Despite CBD’s immense popularity, the cannabidiol industry is quite new and lacks a comprehensive regulatory framework. The result is what has been called a Wild West industry teeming with plenty of unscrupulous sellers who are willing to do and say whatever it takes to make a buck. These bad players have flooded the market with CBD products that are either contaminated with residual solvents, pesticides, heavy metals or THC, or that have barely any actual CBD in them.
Such products are not only ineffective, but they can also cause users to fail drug tests or, even worse, experience health issues. Consumers can take some measures to ensure the CBD they buy is of high quality and can help alleviate their anxiety. Before users purchase a product, they should inspect its certificate of analysis (“COA”). The COA will detail the CBD product’s entire cannabinoid and terpene profile, along with any presence of heavy metals, pesticides, solvent residues and mycotoxins.
Using incorrect dosing. Once a high-quality product has been purchased, consumers should avoid incorrect dosing. Given the state of the cannabis industry, CBD doesn’t have consistent industry dosing recommendations. While the risk for overdosing CBD is quite low, using too little will make it ineffective. Since cannabinoids such as CBD and THC interact with everyone uniquely, users will have to work out which dosage works best for them by experimenting at different levels. Potential consumers should talk to their heart-care providers if they are considering trying to treat their anxiety or other symptoms with CBD, especially if they are pregnant or taking other medication.
Most experts recommend starting with a small dose, perhaps 20 to 40 mg a week. If the effects don’t kick in after a week, consumers can gradually increase the dose by 5 mg every seven days until symptoms start decreasing.
While on the subject of dosage, RYAH Group Inc. offers an excellent interactive platform called RYAH MD on which patients can interact with doctors remotely, while doctors can use that platform to set the dosage for patients.
NOTE TO INVESTORS: The latest news and updates relating to RYAH Group Inc. are available in the company’s newsroom at https://cnw.fm/RYAH
About CNW420
CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.
To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)
For more information please visit https://www.CNW420.com
Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer
Do you have questions or are you interested in working with CNW420? Ask our Editor
CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com
CNW420 is part of the InvestorBrandNetwork.